In:
Maternal-Fetal Medicine, Ovid Technologies (Wolters Kluwer Health), Vol. 2, No. 2 ( 2020-02-26), p. 100-109
Abstract:
Group B streptococcus (GBS) is a leading cause of neonatal infection. Maternal vaginal-rectal colonization with GBS during the intrapartum period is a prerequisite for GBS early-onset disease (EOD). The obstetric measures for effective prevention of GBS EOD include universal prenatal screening by vaginal-rectal culture, correct specimen collection and processing, appropriate implementation of intrapartum antibiotic prophylaxis, and coordination with pediatric care providers. It is now recommended to universal screen GBS between 36 0/7 and 37 6/7 weeks of gestation and to identify groups of women who are eligible for intravenous intrapartum antibiotic prophylaxis as a means of preventing GBS EOD.
Type of Medium:
Online Resource
ISSN:
2641-5895
DOI:
10.1097/FM9.0000000000000041
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2020
detail.hit.zdb_id:
3026863-1
